Eevi Kaasinen

ORCID: 0000-0002-1333-8049
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Bladder and Urothelial Cancer Treatments
  • Uterine Myomas and Treatments
  • Colorectal Cancer Treatments and Studies
  • Urinary and Genital Oncology Studies
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Genomics and Chromatin Dynamics
  • Endometriosis Research and Treatment
  • Genomic variations and chromosomal abnormalities
  • RNA Research and Splicing
  • Ubiquitin and proteasome pathways
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gynecological conditions and treatments
  • Colorectal Cancer Screening and Detection
  • Genomics and Rare Diseases
  • Genetic Associations and Epidemiology
  • Cancer, Lipids, and Metabolism
  • Lymphoma Diagnosis and Treatment
  • RNA and protein synthesis mechanisms
  • Genetics, Bioinformatics, and Biomedical Research
  • Congenital Heart Disease Studies
  • Congenital heart defects research
  • Cancer-related gene regulation

University of Helsinki
2015-2025

Helsinki University Hospital
1988-2024

Blueprint Genetics (Finland)
2024

Genomics (United Kingdom)
2021

Karolinska Institutet
2016-2021

Reaction Biology (Germany)
2014-2016

Medical Genetics Center
2013

Hyvinkää Hospital
1993-2012

Centre for Human Genetics
2010

Institute of Cancer Research
2010

Positives and negatives of methylated CpG When the DNA bases cytosine guanine are next to each other, a methyl group is generally added pyrimidine, generating mCpG dinucleotide. This modification alters structure but can also affect function by inhibiting transcription factor (TF) binding. Yin et al. systematically analyzed effect methylation on binding 542 human TFs (see Perspective Hughes Lambert). In addition some TFs, they found that mCpGs promote others, particularly involved in...

10.1126/science.aaj2239 article EN Science 2017-05-04

Uterine leiomyomas, or fibroids, are benign tumors that affect millions of women worldwide and can cause considerable morbidity. To study the genetic basis this tumor type, we examined 18 uterine leiomyomas derived from 17 different patients by exome sequencing identified tumor-specific mutations in mediator complex subunit 12 (MED12) gene 10. Through analysis 207 additional tumors, determined MED12 is altered 70% (159 225) a total 80 patients. The Mediator 26-subunit transcriptional...

10.1126/science.1208930 article EN Science 2011-08-26

Uterine leiomyomas are benign but affect the health of millions women. A better understanding molecular mechanisms involved may provide clues to prevention and treatment these lesions.We performed whole-genome sequencing gene-expression profiling 38 uterine corresponding myometrium from 30 women.Identical variants observed in some separate tumor nodules suggested that have a common origin. Complex chromosomal rearrangements resembling chromothripsis were feature leiomyomas. These best...

10.1056/nejmoa1302736 article EN New England Journal of Medicine 2013-06-05
Philip Law Maria Timofeeva Ceres Fernández‐Rozadilla Peter Broderick James B. Studd and 95 more Juan Fernández‐Tajes Susan M. Farrington Victoria Svinti Claire Palles Giulia Orlando Amit Sud Amy Holroyd Steven Penegar Evropi Τheodoratou P G Vaughan-Shaw Harry Campbell Lina Zgaga Caroline Hayward Archie Campbell Sarah E. Harris Ian J. Deary John M. Starr Laura Gatcombe Claudia M.A. Pinna Sarah Briggs Lynn Martin Emma Jaeger Archana Sharma‐Oates James E. East Simon J. Leedham Roland Arnold Elaine Johnstone Haitao Wang David Kerr Rachel Kerr Tim Maughan Richard Kaplan Nada Al Tassan Kimmo Palin Ulrika A. Hänninen Tatiana Cajuso Tomas Tanskanen Johanna Kondelin Eevi Kaasinen Antti‐Pekka Sarin Johan G. Eriksson Harri Rissanen Paul Knekt ­Eero Pukkala Pekka Jousilahti Veikko Salomaa Samuli Ripatti Aarno Palotie Laura Renkonen‐Sinisalo Anna Lepistö J. Böhm Jukka‐Pekka Mecklin Daniel D. Buchanan Aung Ko Win John L. Hopper Mark A. Jenkins Noralane M. Lindor Polly A. Newcomb Steven Gallinger David Duggan Graham Casey Per Hoffmann Markus M. Nöthen Karl‐Heinz Jöckel Douglas F. Easton Paul D.P. Pharoah Julian Peto Federico Canzian Anthony J. Swerdlow Rosalind A. Eeles Zsofia Kote‐Jarai Kenneth Muir Nora Pashayan Brian E. Henderson Christopher A. Haiman Fredrick R. Schumacher Ali Amin Al Olama Sara Benlloch Sonja I. Berndt David V. Conti Fredrik Wiklund Stephen J. Chanock Susan M. Gapstur Victoria L. Stevens Catherine M. Tangen Jyotsna Batra Judith A. Clements Henrik Grönberg Johanna Schleutker Demetrius Albanes Alicja Wolk Catharine West Lorelei A. Mucci Géraldine Cancel‐Tassin Stella Koutros

Abstract Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, and has strong heritable basis. We report genome-wide association analysis 34,627 CRC cases 71,379 controls European ancestry that identifies SNPs at 31 new risk loci. also identify eight independent the previously reported loci, further nine loci only identified in Asian populations. use situ promoter capture Hi-C (CHi-C), gene expression, silico annotation methods to likely target genes SNPs. Whilst...

10.1038/s41467-019-09775-w article EN cc-by Nature Communications 2019-05-14

Uterine leiomyomas are common benign smooth muscle tumors that impose a major burden on women's health. Recent sequencing studies have revealed recurrent and mutually exclusive mutations in leiomyomas, suggesting the involvement of molecularly distinct pathways. In this study, we explored transcriptional differences among harboring different genetic drivers, including high mobility group AT-hook 2 (HMGA2) rearrangements, mediator complex subunit 12 (MED12) mutations, biallelic inactivation...

10.1073/pnas.1518752113 article EN Proceedings of the National Academy of Sciences 2016-01-19

Abstract DNA can determine where and when genes are expressed, but the full set of sequence determinants that control gene expression is unknown. Here, we measured transcriptional activity sequences represent an ~100 times larger space than human genome using massively parallel reporter assays (MPRAs). Machine learning models revealed transcription factors (TFs) generally act in additive manner with weak grammar most enhancers increase from a promoter by mechanism does not appear to involve...

10.1038/s41588-021-01009-4 article EN cc-by Nature Genetics 2022-02-21

ARID1A has been identified as a novel tumor suppressor gene in ovarian cancer and subsequently various other types. belongs to the ARID domain containing family, which comprises of 15 genes involved, for example, transcriptional regulation, proliferation chromatin remodeling. In this study, we used exome sequencing data analyze mutation frequency all 25 microsatellite unstable (MSI) colorectal cancers (CRCs) first systematic effort characterize pattern whole family. Genes fulfilled selection...

10.1002/ijc.28705 article EN International Journal of Cancer 2014-01-13

While elevated blood cholesterol has been associated with an increased risk of colorectal cancer (CRC) in observational studies, causality is uncertain. Here we apply a Mendelian randomisation (MR) analysis to examine the potential causal relationship between lipid traits and CRC risk. We used single nucleotide polymorphisms (SNPs) levels total (TC), triglyceride (TG), low‐density lipoprotein (LDL), high‐density (HDL) as instrumental variables (IV). calculated MR estimates for each factor...

10.1002/ijc.30709 article EN International Journal of Cancer 2017-03-25

Abstract Clonal hematopoiesis driven by somatic heterozygous TET2 loss is linked to malignant degeneration via consequent aberrant DNA methylation, and possibly cardiovascular disease increased cytokine chemokine expression as reported in mice. Here, we discover a germline mutation lymphoma family. We observe neither unusual predisposition atherosclerosis nor abnormal pro-inflammatory or expression. The latter finding confirmed cells from three additional unrelated carriers. defect elevates...

10.1038/s41467-019-09198-7 article EN cc-by Nature Communications 2019-03-19

The somatic landscape of pituitary adenomas is largely unknown. Identification alterations aims at better understanding tumor pathology. objective the study was a genome-wide characterization single-nucleotide variants, structural and copy-number aberrations in somatotropinomas. Whole-genome sequencing polymorphism array analyses were performed on 12 fresh-frozen somatotropinomas their corresponding blood samples. All coding variants confirmed by Sanger sequencing. Studied tumors Apart from...

10.1210/jc.2015-3129 article EN The Journal of Clinical Endocrinology & Metabolism 2015-08-17

Uterine leiomyomas (ULs) are benign tumors that a major burden to women's health. A genome-wide association study on 15,453 UL cases and 392,628 controls was performed, followed by replication of the genomic risk in six cohorts. Effects alleles were evaluated view molecular clinical characteristics. 22 loci displayed significant association. The likely predisposition genes could be grouped two biological processes. Genes involved genome stability represented TERT, TERC, OBFC1 - highlighting...

10.7554/elife.37110 article EN cc-by eLife 2018-09-18

Abstract Genomic instability pathways in colorectal cancer (CRC) have been extensively studied, but the role of retrotransposition carcinogenesis remains poorly understood. Although retrotransposons are usually repressed, they become active several human cancers, particular those gastrointestinal tract. Here we characterize retrotransposon insertions 202 tumor whole genomes and investigate their associations with molecular clinical characteristics. We find highly variable activity among...

10.1038/s41467-019-11770-0 article EN cc-by Nature Communications 2019-09-06

The gene desert upstream of the MYC oncogene on chromosome 8q24 contains susceptibility loci for several major forms human cancer. region shows high conservation between and mouse multiple enhancers that are activated in tumor cells. However, role this normal development has not been addressed. Here we show a 538 kb deletion entire super-enhancer mice results 50% to 80% decrease Myc expression tissues. viable no overt phenotype. they resistant tumorigenesis, most cells isolated from them...

10.7554/elife.23382 article EN cc-by eLife 2017-06-06

// Esa Pitkänen 1,2 , Tatiana Cajuso Riku Katainen Eevi Kaasinen Niko Välimäki Kimmo Palin Jussi Taipale 1,3 Lauri A. Aaltonen and Outi Kilpivaara 1 Genome-Scale Biology Research Program, Programs Unit, University of Helsinki, Finland 2 Department Medical Genetics, 3 Science for Life Center, Biosciences Nutrition, Karolinska Institutet, Stockholm, Sweden Correspondence: Aaltonen, email: Keywords : colorectal cancer, genome, sequencing, retrotransposon, L1 Received February 10, 2014 Accepted...

10.18632/oncotarget.1781 article EN Oncotarget 2014-02-14
Coming Soon ...